Up a level |
Liptrott, Neill J ORCID: 0000-0002-5980-8966, Giardiello, Marco ORCID: 0000-0003-0560-4711, McDonald, Tom O ORCID: 0000-0002-9273-9173, Rannard, Steven P ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2017)
Lack of interaction of lopinavir solid drug nanoparticles with cells of the immune system.
NANOMEDICINE, 12 (17).
pp. 2043-2054.
Scarsi, Kimberly K, Sayles, Harlan, Kapungu, Kelvin, Sifuna, Peter, Ippolito, Matthew M, Furl, Renae, Anderson, Matthew J, Ofimboudem, Joelle Dountio, Chongwe, Gershom, Hutter, Jack et al (show 3 more authors)
(2023)
Preferences of Patients and Providers in High-Burden Malaria Settings for Long-Acting Malaria Chemoprevention.
The American journal of tropical medicine and hygiene, 109 (4).
pp. 752-760.
Tatham, Lee M ORCID: 0000-0001-9448-8876, Savage, Alison C ORCID: 0000-0002-5312-9946, Dwyer, Andrew, Siccardi, Marco ORCID: 0000-0002-3539-7867, Scott, Trevor, Vourvahis, Manoli, Clark, Andrew, Rannard, Steven P ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2019)
Towards a Maraviroc long-acting injectable nanoformulation.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 138.
pp. 92-98.
Chang, Yong S, Li, Si-Yang, Pertinez, Henry, Betoudji, Fabrice, Lee, Jin, Rannard, Steven P ORCID: 0000-0002-6946-1097, Owen, Andrew ORCID: 0000-0002-9819-7651, Nuermberger, Eric L and Ammerman, Nicole C
(2023)
Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 67 (7).
e0048123-.